In Vivo and In Silico Evaluation of Analgesic and Hypoglycemic Activities of Methanolic Extract of Codariocalyx gyroids.

Authors

Nilufar Sultana, Mahmudul Hasan, Ishmam Ibnul Arabi, Zobayed Islam, Joana Julhash, Umme Hani, Anika Sikder, Most Afroza Khanam, Abdullah Ripon

Published in

Food science & nutrition. Volume 13. Issue 7. Pages e70485. Epub Jun 29, 2025.

Abstract

Codariocalyx gyroides (Roxb. ex Link) Hassk has long been recognized in traditional medicine for its diverse pharmacological attributes. However, its potential hypoglycemic and analgesic properties remain insufficiently elucidated. This study aimed to comprehensively evaluate the in vivo hypoglycemic and analgesic activities of the methanolic extract of Codariocalyx gyroides (MECG), supported by in silico molecular docking analyses to elucidate possible mechanisms of action. The acetic acid-induced writhing assay investigated the analgesic activity in Swiss albino mice. MECG demonstrated dose-dependent efficacy, significantly reducing writhing counts at 200 mg/kg (45.66) and 400 mg/kg (55.11). The hypoglycemic potential of MECG was assessed in a Streptozotocin (STZ)-induced diabetic murine model, where a 200 mg/kg dose elicited a substantial reduction in plasma glucose levels. Complementary in silico analysis identified stigmasterol and lanosterol as key bioactive compounds. Stigmasterol exhibited a superior docking score (-7.9 kcal/mol) against cyclooxygenase-2 (COX-2) relative to diclofenac (-7.2 kcal/mol), suggesting a mechanistic basis for the observed analgesic effects. Lanosterol demonstrated enhanced affinity (-10.3 kcal/mol) for the sulfonylurea receptor, outperforming the standard hypoglycemic agent Glibenclamide (-9.2 kcal/mol). These findings underscore the therapeutic potential of MECG as a dual-acting pharmacological agent, warranting further investigation to validate its clinical applicability in managing pain and diabetes.

PMID:
40590030
Bibliographic data and abstract were imported from PubMed on 01 Jul 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.